Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jan;88(1):72-4.
doi: 10.1136/bjo.88.1.72.

The relation of Graves' ophthalmopathy to circulating thyroid hormone status

J M Kim  1 , L LaBree, L Levin, S E Feldon
Affiliations

The relation of Graves' ophthalmopathy to circulating thyroid hormone status

J M Kim et al. Br J Ophthalmol. 2004 Jan.

Abstract

Aim: The risk factors and epidemiological data for Graves' ophthalmopathy with and without abnormal circulating thyroid levels were examined to determine the relation of thyroid dysfunction to ophthalmopathy.

Methods: The authors retrospectively evaluated 482 patients seen with Graves' ophthalmopathy. Of these, 413 were classified as having abnormal levels of circulating thyroid hormone (ALTH) and 69 as having normal levels of circulating thyroid hormone (NLTH).

Results: Patients in the NLTH group, compared to the ALTH group, were older on average (56 (SD 13.5) v 52 (15.4)) and had a higher age adjusted body mass index (26.1 (0.8) v 23.4 (0.3)). In addition, a higher percentage of NLTH patients had hypercholesterolaemia. Those in the ALTH group were more likely to be female (76% v 51%), to have a family history of thyroid problems, and to have had eye surgery.

Conclusion: NLTH and ALTH appear to differ from each other in terms of risk factors and epidemiological characteristics. Additionally, thyroid dysfunction seems to be associated with a more severe ophthalmopathy compared to the euthyroid state.

PubMed Disclaimer

References

    1. Doniach D, Florin-Christensen A. Autoimmunity in the pathogenesis of endocrine exophthalmos. Clin Endocrinol Metab 1975;4:341–50.
    1. Volpe R. The pathogenesis of Graves’ disease: an overview. Clin Endocrinol Metab 1978;7:3–29. - PubMed
    1. Sergott RC, Felberg NT, Savino PJ, et al. The clinical immunology of Graves’ ophthalmopathy. Ophthalmology 1981;88:484–7. - PubMed
    1. Perros P, Kendall-Taylor P. Antibodies to orbital tissues in thyroid associated ophthalmopathy. Acta Endocrinol (Copenh) 1992;126:137–42. - PubMed
    1. Gorman CA. Temporal relationship between onset of Graves’ ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin Proc 1983;58:515–19. - PubMed

Publication types

Substances